NORMAN REGIONAL HOSPITAL AUTHORITY
1. Target Overview & Investment Thesis
NORMAN REGIONAL HOSPITAL AUTHORITY is a 322-bed suburban community hospital in CLEVELAND, OK with $540.7M in net patient revenue and a -8.1% operating margin. The hospital serves a payer mix of 29.6% Medicare, 23.5% Medicaid, and 46.9% commercial.
Thesis: Undervalued. Our ML models identify $39.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.1% to -0.8% (+736bps).
| Net Revenue HCRIS | $540.7M |
| Current EBITDA COMPUTED | $-43.9M |
| Operating Margin COMPUTED | -8.1% |
| Occupancy HCRIS | 51.8% |
| Revenue / Bed COMPUTED | $1.7M |
| Net-to-Gross HCRIS | 20.9% |
| Distress Probability ML | 51.7% |
2. Market Context & Competitive Position
OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -8.1% places it above the state median. Among 8 size-comparable peers (161-644 beds), the median margin is -5.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (161-644), prioritizing same-state peers. 8 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| NORMAN REGIONAL HOSPITAL AUTHO (Target) | OK | 322 | $540.7M | -8.1% |
| INTEGRIS BAPTIST MEDICAL CENTE | OK | 615 | $1.02B | -8.7% |
| ST ANTHONY HOSPITAL | OK | 430 | $711.2M | -10.3% |
| MERCY HOSPITAL OKC | OK | 344 | $674.3M | 10.5% |
| HILLCREST MEDICAL CENTER | OK | 424 | $590.1M | -3.3% |
| ST. JOHN MEDICAL CENTER | OK | 419 | $547.8M | -0.5% |
| COMANCHE COUNTY MEMORIAL HOSPI | OK | 201 | $304.2M | -7.9% |
| INTEGRIS SOUTHWEST MEDICAL CEN | OK | 169 | $267.6M | -13.5% |
| SAINT FRANCIS HOSPITAL MUSKOGE | OK | 236 | $196.5M | 11.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $39.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $11.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $10.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $10.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $6.6M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $346K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-43.9M |
| + RCM Uplift | +$39.8M |
| Pro Forma EBITDA | $-4.1M |
| Current Margin | -8.1% |
| Pro Forma Margin | -0.8% |
| WC Released (1x) | $20.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-67.5M | $108.6M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-67.5M | $97.5M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-60.8M | $206.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-60.8M | $207.8M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-74.3M | $-68.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-74.3M | $-99.5M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (23.5%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 51.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 8 hospitals with 161-644 beds
- Same-state prioritization (n=9)
- Comp margins: P25=-9.1% / P50=-5.6% / P75=2.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.